Unlock everything

Company Data

CNPJ

Market Cap

Number of Shares

Listing Segment

IPO Date

Key Indicators

P/E

P/VP

Tag Along

Free float

Viability Seal

ALL ASSETS

Stocks

REITs (BR)

FIAGROs

REITs

Stocks

ETFs

Fixed Income

Indexes

Simplified view

Company Data

CNPJ

01.417.222/0001-77

Market Cap

R$14B

Number of Shares

337,97 mi

Listing Segment

SOMA

IPO Date

18/12/1998

Key Indicators

P/E

11.61

P/VP

1.64

2.35%

Tag Along

Unknown

Free float

1.25%

Viability Seal

Subscribers only

Find out whether the asset is viable or a dud

Unlock the Best FeaturesStock analysis for R$24.90/month on the annual plan.

Price

Current price

R$ 44,50

Fair Price | Graham Formula

Balance Sheet Data

Understand our data

	2025	2024	2023	2022	2021
Total assets - (R$)
Current assets - (R$)
Non-current assets - (R$)
Total liabilities - (R$)
Current liabilities - (R$)
Non-current liabilities - (R$)
Consolidated shareholders' equity - (R$)

Profit and Revenue History

Loading data

Income Statement Data

	Last 12M	2025	2024	2023	2022	2021
Net revenue - (R$)	7,60 bi	7,59 bi	7,02 bi	6,45 bi	5,59 bi	4,43 bi
Costs - (R$)	-4,03 bi	-4,03 bi	-3,91 bi	-3,46 bi	-3,48 bi	-2,91 bi
Gross profit - (R$)	3,56 bi	3,55 bi	3,12 bi	2,99 bi	2,12 bi	1,52 bi
Operating expenses/revenues - (R$)	-769,50 mi	-728,48 mi	-570,13 mi	-474,23 mi	-326,59 mi	-106,93 mi
EBITDA - (R$)	4,02 bi	3,98 bi	3,56 bi	3,43 bi	2,84 bi	2,47 bi
Depreciation/Amortization - (R$)	1,23 bi	1,15 bi	1,02 bi	911,30 mi	1,05 bi	1,06 bi
EBIT - (R$)	2,79 bi	2,82 bi	2,54 bi	2,52 bi	1,79 bi	1,41 bi
Taxes - (R$)	-623,12 mi	-594,87 mi	-632,23 mi	-577,43 mi	-354,79 mi	-346,32 mi
Net income - (R$)	1,30 bi	1,56 bi	1,42 bi	1,20 bi	874,18 mi	699,58 mi

Cash Flow

Understand our data

	2025	2024	2023	2022	2021
Net cash from operating activities - (R$)
Cash generated by operations - (R$)
Net cash from investing activities - (R$)
Net cash from financing activities - (R$)
FX effect on cash and equivalents - (R$)
Increase/Decrease in cash and equivalents - (R$)
Opening cash and equivalents balance - (R$)
Closing cash and equivalents balance - (R$)
Free cash flow - (R$)

Dividend History

Data not available for the selected asset.

Dividend Forecast

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

NOV

DEC

See dividend forecast for other stocks

Fair Price | Bazin Formula

Return Simulator

Company Data

CNPJ

Market Cap

Number of Shares

Listing Segment

IPO Date

Key Indicators

P/E

P/VP

Tag Along

Free float

Viability Seal

Do you consider MRSA3B viable for study?

FA.KE%of the community considers MRSA3B viable for study.

Subscribers-Only Voting

See what thousands of investors think and vote on the assets you consider viable

See Full Voting

Simplified view

Company Data

CNPJ

01.417.222/0001-77

Market Cap

R$14B

Number of Shares

337,97 mi

Listing Segment

SOMA

IPO Date

18/12/1998

Key Indicators

P/E

11.61

P/VP

1.64

2.35%

Tag Along

Unknown

Free float

1.25%

Viability Seal

Subscribers only

Find out whether the asset is viable or a dud

Unlock the Best FeaturesStock analysis for R$24.90/month on the annual plan.

Price

Current price

R$ 44,50

Fair Price | Graham Formula

Viability Classification

Decide what to invest in within seconds

Discover whether an asset is an opportunity or a risk through our seal.

Top-tierCompany considered reliable

ViableViable for study

Needs attentionMay be viable for study, with caveats

AvoidNot considered viable for study

Balance Sheet Data

Understand our data

	2025	2024	2023	2022	2021
Total assets - (R$)
Current assets - (R$)
Non-current assets - (R$)
Total liabilities - (R$)
Current liabilities - (R$)
Non-current liabilities - (R$)
Consolidated shareholders' equity - (R$)

Profit and Revenue History

Loading data

Income Statement Data

	Last 12M	2025	2024	2023	2022	2021
Net revenue - (R$)	7,60 bi	7,59 bi	7,02 bi	6,45 bi	5,59 bi	4,43 bi
Costs - (R$)	-4,03 bi	-4,03 bi	-3,91 bi	-3,46 bi	-3,48 bi	-2,91 bi
Gross profit - (R$)	3,56 bi	3,55 bi	3,12 bi	2,99 bi	2,12 bi	1,52 bi
Operating expenses/revenues - (R$)	-769,50 mi	-728,48 mi	-570,13 mi	-474,23 mi	-326,59 mi	-106,93 mi
EBITDA - (R$)	4,02 bi	3,98 bi	3,56 bi	3,43 bi	2,84 bi	2,47 bi
Depreciation/Amortization - (R$)	1,23 bi	1,15 bi	1,02 bi	911,30 mi	1,05 bi	1,06 bi
EBIT - (R$)	2,79 bi	2,82 bi	2,54 bi	2,52 bi	1,79 bi	1,41 bi
Taxes - (R$)	-623,12 mi	-594,87 mi	-632,23 mi	-577,43 mi	-354,79 mi	-346,32 mi
Net income - (R$)	1,30 bi	1,56 bi	1,42 bi	1,20 bi	874,18 mi	699,58 mi

Cash Flow

Understand our data

	2025	2024	2023	2022	2021
Net cash from operating activities - (R$)
Cash generated by operations - (R$)
Net cash from investing activities - (R$)
Net cash from financing activities - (R$)
FX effect on cash and equivalents - (R$)
Increase/Decrease in cash and equivalents - (R$)
Opening cash and equivalents balance - (R$)
Closing cash and equivalents balance - (R$)
Free cash flow - (R$)

Dividend History

Data not available for the selected asset.

Dividend Forecast

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

NOV

DEC

See dividend forecast for other stocks

Fair Price | Bazin Formula

Return Simulator

All about MRSA3B

Sector
Capital Goods and Services
Subsector
Transportation
Segment
Railroads
CNPJ
01.417.222/0001-77
Average Daily Liquidity
R$ 22.250,00

Revenues and Countries

	2025	2024	2023	2022	2021
Revenues - (R$)	7,59 bi	7,02 bi	6,45 bi	5,59 bi	4,43 bi
Exploração de concessão onerosa no serviço público de transporte ferroviário de carga - (R$)	7,59 bi	7,02 bi	6,45 bi	5,59 bi	4,43 bi
Countries - (R$)	7,59 bi	7,02 bi	6,45 bi	5,59 bi	4,43 bi
Brasil - (R$)	7,59 bi	7,02 bi	---	---	---
Mercado Doméstico Brasileiro - (R$)	---	---	6,45 bi	5,59 bi	4,43 bi

Filings and Reports

Date	Title

News

Brazilian Stock Comparator

Indicator	MRSA3B	RAIL3	MRSA5B
P/E	11.61	22.43	9.92
P/B	1.64	1.90	1.40
Dividend yield	2.35%	0.73%	3.03%
Market cap	R$ 14 bi	R$ 28 bi	R$ 14 bi
Net debt/EBITDA	1.42	2.66	1.42
Net margin	17.05%	8.53%	17.05%
AVG. DAILY LIQ.	R$ 22.250,00	R$ 192.742.597,55	-

Detailed comparison

ALL ASSETS

Stocks

REITs (BR)

FIAGROs

REITs

Stocks

ETFs

Fixed Income

Indexes

Subscribers only

Price

Fair Price | Graham Formula

Balance Sheet Data

Profit and Revenue History

Income Statement Data

Cash Flow

Dividend History

Dividend Forecast

Fair Price | Bazin Formula

Return Simulator

Do you consider MRSA3B viable for study?

Subscribers-Only Voting

Do you consider MRSA3B viable for study?

Subscribers-Only Voting

Comments

Indicators

Indicator History

Dividend yield

P/E

P/B

EPS

BVPS

EV/EBITDA

EV/EBIT

P/EBITDA

P/EBIT

P/S (PSR)

P/OCF

P/FCF

EV/Revenue

EV/OCF

EV/FCF

Earnings yield

Enterprise value

Market cap

Net debt/EBITDA

Net debt/Equity

Net debt

Current ratio

Equity/Assets

Liabilities/Assets

Quick ratio

Cash ratio

Gross margin

EBITDA margin

EBIT margin

Net margin

ROE

ROIC

ROA

Payout

Asset turnover

Revenue CAGR (5Y)

EBITDA CAGR (5Y)

EBIT CAGR (5Y)

Net income CAGR (5Y)

Related assets

Subscribers only

Price

Fair Price | Graham Formula

Viability Classification

Decide what to invest in within seconds

How does it work?

What criteria do we analyze?

Balance Sheet Data

Profit and Revenue History

Income Statement Data

Cash Flow

Dividend History

Dividend Forecast